My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


OpenAI, Anthropic, SpaceX IPOs Could End Big...
Adobe Pauses Price Hikes For 'Short-Term' AI...
Trump Says Iran 'Better Get Their Act Togethe...
GameStop Didn't Make Money With Its Bitcoin B...
Value Investors Question SpaceX's Record IPO:...
Google Sounds Alarm On Active Oracle PeopleSo...
Chinese Customers Can Now Order NVIDIA's Vera...
SpaceX's IPO Could Spark A Venture Capital Fr...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) (NYSE: NVS)

    Overview
    current price
    $153.07
    $153.07
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    153.07
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    1.54 M
    1 day
    0.00 - 0.00
    52 weeks
    112.34 - 170.46
    p/e
    25.86
    beta
    0.4430
    market cap
    311.47 B
    dividend yield
    2.62%
    Industry
    -
    NVS by TradingView
    News and Commentary
    Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans Super Bowl LX aired on Sunday, Feb. 8, 2026, and the Seattle Seahawks defeated the New England Patriots 29-13, in a game that saw 30 of the 42 total points scored in the fourth q...
    Novartis Builds US Drug Reserves Against Potential Tariffs Novartis AG (NVS 
    Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva Novartis AG (NVS 
    3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs On July 8, US President Donald Trump shook the biopharmaceutical sector by announcing a tariff of up to 200% on pharmaceuticals, which would take effect "very soon." 80% of presc...
    Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US AstraZeneca plc (AZN&nb...
    Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'Th... Alphabet Inc.'s (GOOG&...
    Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Com... Novo Nordisk A/S (NVS&n...
    Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainti... Novartis AG (NVS 
    Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...
    US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could... Monday, the U.S. Department of Health and Human Services (HHS) announced that Medicare enrollees will benefit from reduced prices on 54 drugs through Medicare Part B, effective f...
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    US Says China To Buy At Least $17 Billion Worth Agricultural Goods Annually After Trump-Xi Meet
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?